Contraindication of ibugesic in neonates

Reading File

Finding Sources

Searching the Web

ibugesic ibuprofen contraindication neonates

Finding Sources

Reading File

Finding Sources

Here is a comprehensive answer on the contraindications of Ibugesic (ibuprofen) in neonates:

Contraindications of Ibugesic (Ibuprofen) in Neonates

Ibugesic is a brand name for ibuprofen, a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis via COX-1 and COX-2 inhibition. Ibuprofen is contraindicated in neonates (under 1 month of age) and should not be used in infants under 6 months without direct physician supervision. The contraindications are largely mechanistic - because neonates depend heavily on prostaglandins for several critical physiological functions.

1. Risk of Neonatal Pulmonary Hypertension

Prostaglandins (PGI2 and PGE2) are essential for maintaining pulmonary vascular relaxation after birth. Ibuprofen, by inhibiting prostaglandin synthesis, can cause:

Constriction of the pulmonary vasculature
Persistent pulmonary hypertension of the newborn (PPHN)
Right heart strain and failure

Primary pulmonary hypertension in the neonate has been associated with fetal/neonatal exposure to NSAIDs including ibuprofen, naproxen, aspirin, and indomethacin. - Creasy & Resnik's Maternal-Fetal Medicine

2. Renal Toxicity / Acute Kidney Injury (AKI)

Neonatal kidneys - especially in preterm infants - are functionally immature and heavily reliant on prostaglandin-mediated renal blood flow. Inhibiting prostaglandins with ibuprofen causes:

Renal vasoconstriction and decreased GFR
Oliguria and acute tubular necrosis
Risk of irreversible renal failure

Studies have found that ibuprofen exposure in perinatally exposed infants was associated with a significantly increased odds ratio (OR ~2) for neonatal AKI. Neonates in intensive care are particularly susceptible due to programmed risk, low nephron number, and concurrent nephrotoxin exposure. - Brenner & Rector's The Kidney

3. Ductal Constriction / Patent Ductus Arteriosus (PDA) Concerns

Prostaglandins (PGE2) are required to keep the ductus arteriosus patent in utero and in early neonatal life. Ibuprofen causes:

Premature constriction of the ductus arteriosus in utero
Paradoxically, in preterm infants with a hemodynamically significant PDA, ibuprofen is used therapeutically - but this must be under strict neonatal ICU protocols
Outside these protocols, unmonitored use risks ductal compromise and cardiac decompensation

4. Platelet Dysfunction and Bleeding Risk

Ibuprofen reversibly inhibits COX-1 in platelets, impairing thromboxane A2-mediated platelet aggregation. In neonates:

Physiological platelet function is already immature
Risk of intraventricular hemorrhage (IVH) and other bleeding complications is elevated
This is especially serious in preterm neonates

5. Oligohydramnios (if given prenatally) and Neonatal Renal Insufficiency

NSAIDs given to mothers near term inhibit fetal renal prostaglandins and ADH pathways, reducing fetal urine output. This can carry over postnatally and lead to neonatal renal insufficiency and death.

6. General Contraindications (also applicable to neonates)

Contraindication	Reason
Hypersensitivity to ibuprofen or other NSAIDs	Anaphylaxis/anaphylactoid reactions
Active GI bleeding or ulceration	COX-1 inhibition reduces gastric mucosal protection
Severe hepatic impairment	Impaired drug metabolism; risk of toxicity
Severe renal failure	Already compromised in sick neonates
Severe heart failure	Fluid retention worsens cardiac output
Coagulation disorders	Additive bleeding risk

Key Rule

Ibuprofen (Ibugesic) must NOT be given to neonates (< 1 month) or infants under 6 months of age unless explicitly prescribed and monitored by a physician. The Medsafe CMI for Ibugesic explicitly states it is "not for use in children aged younger than 6 years... unless on doctor's advice."

The most pharmacologically specific contraindications in neonates relate to pulmonary hypertension, renal AKI, ductal constriction, and platelet/bleeding risk - all driven by the neonatal dependence on prostaglandin-mediated physiology.

This is a shared conversation. Sign in to Orris to start your own chat.